jump to content jump to footer
Research poster presentation on standardized tumor response assessments using mint Lesion at the NCCN Annual Conference 2026

NCCN 2026: Memorial Sloan Kettering Cancer Center Presents Research on Structured Tumor Response Assessments with mint Lesion

Big congratulations to Steven Philemond and Alison Chiaramonte of Memorial Sloan Kettering Cancer Center for presenting their research poster “Use of Electronic Solution Supplemented with Portfolio of Tailored Resources Improves Tumor Response Assessment for Patients” at the recent 2026 NCCN Annual Conference.

Their work dives into how their institutional investment into standardizing clinical trial response assessments leveraging mint Lesion has improved operational efficiency and data quality in real, measurable ways since implementation in 2019:

  • 32% reduction in data deficiencies found during internal audits
  • Principal Investigator use increased from 10% (2019) to 78% (2024)
  • Integration with existing clinical research workflows enhanced inter-disciplinary collaboration

Benefits/Outcomes

Data Integrity

  • Quality: Automated calculations
  • Completeness: Fields of information required before sign-offs
  • Record-keeping: Legibility, timestamps
  • Privacy: Access granted to assessments by administrators
  • Reduction in deficiencies found by internal quality assurance audits

Reduce Administrative Burden

  • Automated back-end processes, such as automatically sending assessments to Epic EMR
  • Radiologist, Investigator, and Study Team user groups avoid using manual methods and sending them around for input and sign-offs
  • Share data with trial sponsors more readily

Ease of Use

  • Define a clear workflow among stakeholders to complete assessments
  • Tumor Response Assessments are housed in one location to improve accessibility for clinical staff and audit preparedness
  • Scalable to accommodate increase in assessment volume as well as new protocol criteria and  unique protocol structures

Financial

  • Bill more accurately for assessments
  • An assessment is never 'lost' and has to be redone

Read the full poster by clicking here.

Mint Medical is proud to support Memorial Sloan Kettering Cancer Centers's mission of ending cancer for life and can't wait to see what they accomplish next.

 If you're looking to transform the intersection of clinical imaging data in cancer research and how Mint Lesion can support your research aspirations, let's talk.

 

 

Success Story mintLesion Clinical Trials Standardized Reading Procedures Data Analysis Therapy Response Assessment Structured Reporting

Related Resources

Centralized Management for Clinical Trial Communications and Workflows
Requests for radiological clinical trial evaluations frequently rely on fragmented methods such as emails, phone calls, and spreadsheets. This…
mint Lesion usage during a clinical trial read, featuring the TGRM export tool.
Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer
For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…
Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.
The two-day “RECIST and Beyond” workshop at radCIO Cologne offered intensive hands-on training on RECIST, iRECIST, mRECIST and LI-RADS, with real-case reporting performed directly in mint Lesion.
Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging
How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?